[HTML][HTML] Engineering CAR-T cells for next-generation cancer therapy

M Hong, JD Clubb, YY Chen - Cancer cell, 2020 - cell.com
T cells engineered to express chimeric antigen receptors (CARs) with tumor specificity have
shown remarkable success in treating patients with hematologic malignancies and …

Engineering CAR-T Cells for Next-Generation Cancer Therapy.

M Hong, JD Clubb, YY Chen - Cancer cell, 2020 - escholarship.org
T cells engineered to express chimeric antigen receptors (CARs) with tumor specificity have
shown remarkable success in treating patients with hematologic malignancies and …

[引用][C] Engineering CAR-T Cells for Next-Generation Cancer Therapy

M Hong, JD Clubb, YY Chen - Cancer Cell, 2020 - cir.nii.ac.jp
Engineering CAR-T Cells for Next-Generation Cancer Therapy | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

[HTML][HTML] Engineering CAR-T Cells for Next-Generation Cancer Therapy

M Hong, JD Clubb, YY Chen - Cancer Cell, 2020 - Elsevier
T cells engineered to express chimeric antigen receptors (CARs) with tumor specificity have
shown remarkable success in treating patients with hematologic malignancies and …

Engineering CAR-T Cells for Next-Generation Cancer Therapy

M Hong, JD Clubb, YY Chen - Cancer cell, 2020 - pubmed.ncbi.nlm.nih.gov
T cells engineered to express chimeric antigen receptors (CARs) with tumor specificity have
shown remarkable success in treating patients with hematologic malignancies and …

Engineering CAR-T Cells for Next-Generation Cancer Therapy.

M Hong, JD Clubb, YY Chen - Cancer Cell, 2020 - europepmc.org
T cells engineered to express chimeric antigen receptors (CARs) with tumor specificity have
shown remarkable success in treating patients with hematologic malignancies and …

[HTML][HTML] Engineering CAR-T Cells for Next-Generation Cancer Therapy

M Hong, JD Clubb, YY Chen - Cancer Cell, 2020 - cell.com
T cells engineered to express chimeric antigen receptors (CARs) with tumor specificity have
shown remarkable success in treating patients with hematologic malignancies and …